PIQ 1.44% 70.5¢ proteomics international laboratories ltd

Promarker D Promarker D, developed by Proteomics, is a...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 9,509 Posts.
    lightbulb Created with Sketch. 661
    Promarker D Promarker D, developed by Proteomics, is a predictive screening tool. While yet to be approved by the Therapeutic Goods Administration, it offers an insight into the growing ability to use blood checks as a preventive diagnostic. It claims the ability to predict the development of diabetic kidney disease up to four years in advance, allowing people the chance to act on medications and lifestyle changes earlier, diminishing the extent of kidney damage. Promarker D is conducted through a routine blood check which is sent to a laboratory for analysis, with results returned to the health professional.

    Above you find the part where Promarker D is mentioned in the article
 
watchlist Created with Sketch. Add PIQ (ASX) to my watchlist
(20min delay)
Last
70.5¢
Change
0.010(1.44%)
Mkt cap ! $92.35M
Open High Low Value Volume
71.0¢ 71.0¢ 69.0¢ $10.51K 14.9K

Buyers (Bids)

No. Vol. Price($)
2 101449 69.0¢
 

Sellers (Offers)

Price($) Vol. No.
71.0¢ 10000 1
View Market Depth
Last trade - 12.53pm 15/11/2024 (20 minute delay) ?
PIQ (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.